Impact of Targeted Therapy on Cancer-Related Cognitive Impairment | MicrobiomeTrials← Back to trialsNCT07638007
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-11-21Est. Completion: 2029-02-28
Enrollment target: 400 participants Locations- University of Rochester NCORP Research Base, Rochester, New York, United States
Other microbiome trials you might be interested in
ICU DeliriumCritical Illness
Delirium is a common syndrome in intensive care unit (ICU) patients. Those experiencing delirium may suddenly feel confu…
Nashville, United StatesEst. completion Dec 31, 2026
Renal Insufficiency, Chronic
Preserving kidney function and improving the transition from CKD to End stage renal disease (ESRD) is a research and hea…
Villejuif, FranceCompleted May 3, 2016